Stem Cell Clinic

Platelet Rich Plasma Market Outlook 2020 Scope and Business Growth Overview by Regions, Latest Trends, and Opportunities Forecast to 2024 – The Daily…

By adminNovember 9, 2020Platelet Rich Plasma Injections

Octapharma AG

For More Information or Query or Customization Before Buying, Visit at https://www.industryresearch.co/enquiry/pre-order-enquiry/13999558

Key Market Trends:

Pure PRP Segment by Type is Expected to Hold the Largest Market Share

The pure PRP segment of the global platelet rich plasma market is believed to have the largest market share.

The prime factor responsible for the growth of this segment is the significance of this type of platelet plasma for the person. Pure PRP has an edge over traditional PRP, as it requires a two-step concentration process that helps in eliminating unwanted red blood cells (RBCs) and neutrophils. RBCs (that have no therapeutic effects for regeneration) can create a more viscous solution that can be more painful when injected. Neutrophils, a type of white blood cell, have inflammatory components that may increase pain and inflammation post-treatment.

Pure PRP helps the stem cells and regenerative cells in the repair and in rebuilding the damaged tissue. This ultimately speeds up the healing process and reduces pain. In addition, it promotes increased strength and improves the overall function. Therefore, owing to the contribution of pure PRP in the healing process and the rising use of it as a blood product, the segment is expected to dominate the market in the coming future.

North America Dominates the Market and is Expected to Continue the Same Trend for Next Few Years

North America currently dominates the platelet-rich plasma market and is expected to continue its stronghold for a few more years. The United States is a major market, and this is mainly due to the US governments initiatives to develop blood products. In addition, the emergence and adoption of novel technologies are going to help the market in a positive manner.

Competitive Landscape:

Most of the companies present in the market are efficient at the technological front, but require significant support for enhancing their services and expanding their businesses. Thus, mergers and acquisitions offer significant opportunities to gain the attention of a large number of providers across developed regions.

Purchase this Report (Price 4250 USD for single user license) https://www.industryresearch.co/purchase/13999558

Platelet Rich Plasma Market Covers Following Points in TOC:

1 INTRODUCTION 1.1 Study Deliverables 1.2 Study Assumptions 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS 4.1 Market Overview 4.2 Market Drivers 4.2.1 Rising Incidences of Sports Injuries 4.2.2 Increasing Number of Androgenic Alopecia Patients 4.2.3 Growing Use of Platelet-rich Plasma in Various Therapeutic Areas 4.2.4 Rising Prevalence of Arthritis 4.3 Market Restraints 4.3.1 Stringent Regulatory Policies 4.3.2 High Prices of Plasma Therapy 4.4 Porters Five Forces Analysis 4.4.1 Threat of New Entrants 4.4.2 Bargaining Power of Buyers/Consumers 4.4.3 Bargaining Power of Suppliers 4.4.4 Threat of Substitute Products 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION 5.1 By Type 5.1.1 Pure PRP 5.1.2 Leukocyte-rich PRP 5.1.3 Pure Platelet-rich Fibrin 5.1.4 Leukocyte-rich Fibrin 5.2 By Source 5.2.1 Autologous 5.2.2 Allogenic 5.3 By Application 5.3.1 Orthopedic 5.3.1.1 Arthritis 5.3.1.2 Chronic Tendinitis 5.3.1.3 Bone Repair and Regeneration 5.3.2 Dermatology 5.3.2.1 Androgenic Alopecia 5.3.2.2 Plastic Surgery 5.3.2.3 Cardiac Muscle Injury 5.3.2.4 Dental 5.3.2.5 Nerve Injury 5.3.2.6 Other Applications 5.3.3 By End User 5.3.3.1 Hospitals and Clinics 5.3.3.2 Research Institutes 5.3.3.3 Other End Users 5.4 Geography 5.4.1 North America 5.4.1.1 United States 5.4.1.2 Canada 5.4.1.3 Mexico 5.4.2 Europe 5.4.2.1 Germany 5.4.2.2 United Kingdom 5.4.2.3 France 5.4.2.4 Italy 5.4.2.5 Spain 5.4.2.6 Rest of Europe 5.4.3 Asia-Pacific 5.4.3.1 China 5.4.3.2 Japan 5.4.3.3 India 5.4.3.4 Australia 5.4.3.5 South Korea 5.4.3.6 Rest of Asia-Pacific 5.4.4 Middle East & Africa 5.4.4.1 GCC 5.4.4.2 South Africa 5.4.4.3 Rest of Middle East & Africa 5.4.5 South America 5.4.5.1 Brazil 5.4.5.2 Argentina 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE 6.1 Company Profiles 6.1.1 Bio Product Laboratory Ltd (BPL) 6.1.2 Biolife Plasma Services 6.1.3 Biotest AG 6.1.4 Cambryn Biologics LLC 6.1.5 China Biologic Products Inc. 6.1.6 CSL Ltd 6.1.7 Grifols International SA 6.1.8 Kedrion SpA 6.1.9 LFB SA 6.1.10 Octapharma AG

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Name: Ajay More

Phone: US +14242530807/ UK +44 20 3239 8187

Email: [emailprotected]

Our Other Reports:

Wearable Inertial Sensors Market Size, Share Forecast 2020 | Growth Insights, Business Trends by Types and Applications, Opportunities and Challenges Forecast to 2025

Monofilament Evaluator Market Business Growth Rate, Top Key Players with COVID-19 Outbreak, Regional Overview, Upcoming Trends, Industry Size & Share Forecast to 2026

Resorcinol Formaldehyde Latex Market by Growth Size Analysis 2020 | Future Trends by Regions, Prominent Players, Global Developments Status, Industry Segments with Business Share Forecast to 2026

Lighting as a Service (LaaS) Market Size, Share Forecast 2020 | Growth Insights, Business Trends by Types and Applications, Opportunities and Challenges Forecast to 2025

Artificial Neural Networks Market Growth Factors by Latest Developments 2020 | Future Demand Status, Business Strategies, Opportunities, Trends, Industry Size and Share Forecast to 2026

Waste Paper Recycling Market Size 2020 | Global Trends Analysis by Growth Demand, Key Players by Share Analysis Forecast to 2025 Report by Industry Research.co

Telco Digital AI Assistants & Chatbots Market Size 2020 | Global Manufacturers with Forthcoming Developments, Regional Overview, Growth Analysis by Key Findings, Demand Status Forecast to 2025

Spunmelt Nonwoven Fabrics Market Share and Size Analysis 2020 Global Industry Segments by Regions, Types and Applications, Future Demand Status, Growth Dynamics with COVID-19 Impact till 2026

Ultra High Purity Boron Market Share, Growth Analysis 2020 Industry Size with Regional Segmentations, Business Challenges and Opportunities Forecast to 2024

LED Face Masks Market Business Growth Rate, Top Key Players with COVID-19 Outbreak, Regional Overview, Upcoming Trends, Industry Size & Share Forecast to 2026

Gas Industrial Tumble Dryer Market Growth Share and Development Analysis 2020 | Global Driving Factors by Manufacturers, CAGR Status with Size, Latest Challenges and Opportunities Forecast to 2026

3D Imaging in 5G Smartphone Market Growth Share and Development Analysis 2020 | Global Driving Factors by Manufacturers, CAGR Status with Size, Latest Challenges and Opportunities Forecast to 2026

Link:
Platelet Rich Plasma Market Outlook 2020 Scope and Business Growth Overview by Regions, Latest Trends, and Opportunities Forecast to 2024 - The Daily...

Platelet-rich Plasma Market To Witness the Highest Growth Globally in Coming Years 2020-2025 – The Daily Philadelphian

By adminNovember 9, 2020Platelet Rich Plasma Injections

The Platelet-rich Plasma Market Research Report 2020 to 2025 presents an in-depth assessment of the Station Platelet-rich Plasma It provides the industry overview with market growth analysis with a historical & futuristic perspective considering the following parameters; cost, revenue, demands, and supply data (as applicable). The bottom-up approach was used to estimate the global market size of Station Platelet-rich Plasma based on end-use applications in the various regions, in terms of USD million. The report covers the historic growth of the market, the impact of the COVID-19, and also forecasts its recovery post-COVID-19. The report also presents forecasts for Platelet-rich Plasma investments from 2020 to 2025.

Top Companies in the Global Platelet-rich Plasma Market:Arthrex, Inc., Cambryn Biologics LLC, China Biologic Products Inc., DePuy Synthes, Dr. PRP USA LLC, EmCyte Corporation, Glofinn Oy, T-Biotechnology, Terumo BCT, Inc., and Zimmer Biomet

The platelet-rich plasma (PRP) market is expected to register a CAGR of approximately 14.2%, over the forecast period.

Market OverviewThe key factors that are augmenting the growth of the market include rising incidences of sports injuries, an increasing number of cosmetic and surgical procedures, and growing use of platelet-rich plasma in various therapeutic areas. PRP contains at least seven growth factors, and it can be used for various treatments, such as chronic tendon injuries, acute ligament, and muscle injuries, surgery, knee arthritis, fractures, and pain. In orthopedics, the use of PRP is expected to increase over the period. PRP is increasingly being used in the treatment of acute sports injuries, such as muscle injuries. The popularity of PRP is on the rise, but its true effectiveness is yet to be fully established. The PRP is thus widely used in surgery to repair torn knee ligaments, such as the anterior cruciate ligament (ACL). The PRP facilitates the fast healing of the tissue after surgical procedures. Several research studies are currently being conducted to evaluate the effectiveness of PRP in other treatment areas, such as in the case of herniated disc and hair loss. The use of PRP has grown widely in different therapeutic areas, owing to the increasing availability and ability to enable faster healing.

Get a Sample PDF Copy of the Latest Research on Platelet-rich Plasma Market 2020 Before the purchase https://www.marketinsightsreports.com/reports/10192354530/platelet-rich-plasma-market-growth-trends-and-forecasts-2020-2025/inquiry?Mode=46

Market InsightsThe Orthopedics Segment by Application is Expected to Hold the Largest Market Share According to the US Arthritis Foundation, arthritis is the leading cause of disability among adults in the country. By conservative estimates, about 54 million adults were diagnosed with arthritis and almost 300,000 children were suffering from arthritis or rheumatic condition (2017-2018). Despite not being considered the standard practice, a growing number of people are opting for PRP injections, to treat an expanding list of orthopedic conditions, including osteoarthritis. It is most commonly used for knee osteoarthritis but may be used on other joints as well. While treating osteoarthritis with platelet-rich plasma, a doctor injects PRP directly into the affected joint, in order to reduce pain, improve joint function, and slow, halt, or even repair damage to the cartilage. In such cases, platelet-rich plasma is derived from a sample of the patients own blood. Platelet-rich plasma therapy is thus witnessing a significant rise in its popularity and acceptance, for treating arthritis, owing to the fact that it inhibits inflammation, reduces the rate of progression of osteoarthritis, stimulates the formation of new cartilage, and increases the production of natural lubricating joint fluid, thus, easing painful joint friction, and it also contains proteins that alter a patients pain receptors and reduces pain sensation. Hence, the aforementioned factors are expected to fuel the growth of the arthritis segment.

North America Dominates the Market and is Expected to Depict Similar Trend Over the Forecast Period The market growth in the country can be attributed to several factors, including the rise in the prevalence of several disorders, such as arthritis, well-established healthcare infrastructure, better regulatory framework, and government support. As per a survey conducted by the Centers for Disease Control and Prevention (CDC), in the United States, in 2018, about 54.4 million adults (22.7%) were diagnosed with common arthritis, rheumatoid arthritis, and gout. Moreover, in the country, due to the growing aging population, the prevalence of doctor-diagnosed arthritis is expected to rise significantly, over the forecast period. Osteoarthritis is the most prevalent type of arthritis, and it affects about 31 million Americans every year.

Regions Are covered By Platelet-rich Plasma Market Report 2020 To 2025.

North America, Europe, China, Japan, Southeast Asia, India. North America (USA, Canada, and Mexico). Europe (Germany, France, UK, Russia, and Italy). Asia-Pacific (China, Japan, Korea, India, and Southeast Asia).

The report has 150 tables and figures browse the report description and TOChttps://www.marketinsightsreports.com/reports/10192354530/platelet-rich-plasma-market-growth-trends-and-forecasts-2020-2025?Mode=46

Significant Features that are under Offering and Key Highlights of the Reports:

-Detailed overview of Platelet-rich Plasma Market -Changing the Platelet-rich Plasma market dynamics of the industry -In-depth market segmentation by Type, Application, etc. -Historical, current and projected Platelet-rich Plasma market size in terms of volume and value Recent industry trends and developments -Competitive landscape of Platelet-rich Plasma Market -Strategies of key players and product offerings -Potential and niche segments/regions exhibiting promising growth.

Frequently Asked Questions about Platelet-rich Plasma market:

What are the recent developments and government policies? Why might we forecast a downturn in a particular economy next year? Why do we say the currency is set to appreciate? What countries and sectors offer the highest potential? Where are the greatest dangers?

We Also Offer Customization on report based on specific client Requirementcountry Level analysis for any 5 countries of your choice. Competitive analysis of any 5 key market players. 40 analyst hours to cover any other data point.

All the reports that we list have been tracking the impact of COVID-19 on the market. Both upstream and downstream of the entire supply chain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.

ABOUT US

Market Insights Reports is an online market research reports library of 500,000 in-depth studies of over 5000 micro markets. Market Insights Reports offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food, and beverages, water, advanced materials, and much more.

Irfan Tamboli Market Insights Reports Phone: + 1704 266 3234 | +91-750-707-8687[emailprotected] | [emailprotected]

Stem Cell Banking Market To See Massive Growth By 2027| Cryo-Save AG, StemCyte India Therapeutics, SMART CELLS PLUS, Vita 34, LifeCell – PRnews Leader

By adminNovember 9, 2020Stem Cell Treatment

Stem cell banking or preservation is a combined process of extraction, processing and storage of stem cells, so that they may be used for treatment of various medical conditions in the future, when required. Stem cells have the amazing power to get transformed into any tissue or organ in the body. In recent days, stem cells are used to treat variety of life-threatening diseases such as blood and bone marrow diseases, blood cancers, and immune disorders among others.

The study provides details such as the market share, Market Insights, Strategic Insights, Segmentation and key players in the Stem Cell Banking Market.

Download PDF Report Sample with statistical info @ https://www.theinsightpartners.com/sample/TIPBT00002082/

(*If you have any special requirements, please let us know and we will offer you the report as you want.)

The global stem cell banking market is segmented on the basis of source, service type, and application. The source segment includes, placental stem cells (PSCS), dental pulp-derived stem cells (DPSCS), bone marrow-derived stem cells (BMSCS), adipose tissue-derived stem cells (ADSCS), human embryo-derived stem cells (HESCS), and other stem cell sources. Based on service type the market is segmented into, sample processing, sample analysis, sample preservation and storage, sample collection and transportation. Based on application, the market is segmented as, clinical applications, research applications, and personalized banking applications.

Note The Covid-19 (coronavirus) pandemic is impacting society and the overall economy across the world. The impact of this pandemic is growing day by day as well as affecting the supply chain. The COVID-19 crisis is creating uncertainty in the stock market, massive slowing of supply chain, falling business confidence, and increasing panic among the customer segments. The overall effect of the pandemic is impacting the production process of several industries. This report on Stem Cell Banking Market provides the analysis on impact on Covid-19 on various business segments and country markets. The reports also showcase market trends and forecast to 2027, factoring the impact of Covid -19 Situation.

The researchers have analysed the competitive advantages of those involved in the industries or in the In Stem Cell Banking industry. While historical years were taken as 2020 2027, the base year for the study was 2020. Similarly, the report has given its projection for the year 2020 apart from the outlook for years 2020 2027.

Some of the Major Market Players Are:

Cordlife, ViaCord (A Subsidiary of PerkinElmer), Cryo-Save AG, StemCyte India Therapeutics Pvt. Ltd., Cryo-Cell International, Inc., SMART CELLS PLUS, Vita 34, LifeCell, Global Cord Blood Corporation, CBR Systems

The objective of the researchers is to find out the sales, value, and status of the In Stem Cell Banking industry at the international levels. While the status covers the years of 2020 2027, the forecast is for the period 2020 2027 that will enable market players to not only plan but also execute strategies based on the market needs.

The study wanted to focus on key manufacturers, competitive landscape, and SWOT analysis for the In Stem Cell Banking Market. Apart from looking into the geographical regions, the report concentrated on key trends and segments that are either driving or preventing the growth of the industry. Researchers have also focused on individual growth trends besides their contribution to the overall market.

An outline of the regional analysis:

In Stem Cell Banking market recent innovations and major events.

Additional highlights of the In Stem Cell Banking market report:

Purchase This Report at: https://www.theinsightpartners.com/buy/TIPBT00002082/

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

Call: +1-646-491-9876

Email: [emailprotected]

Original post:
Stem Cell Banking Market To See Massive Growth By 2027| Cryo-Save AG, StemCyte India Therapeutics, SMART CELLS PLUS, Vita 34, LifeCell - PRnews Leader

It’s time for Kentucky to talk to expectant parents about benefits of cord blood banking – Courier Journal

By adminNovember 9, 2020Stem Cell Treatment

Paula Grisanti, Opinion contributor Published 6:20 a.m. ET Nov. 9, 2020

This year, Nov.17 has been designated World Cord Blood Day, an annual event to raise awareness for the life-saving benefits of cord blood transplants while educating parents, health professionals and the general public about the need to preserve these precious cells.

Cord blood transplants are being used to treat more than 80 different diseases and conditions including blood cancers like leukemia and lymphoma, neuroblastoma (the most common cancer in infants), bone-marrow failure disorders, inherited blood disorders and rare immune system disorders. They are also showing new promise for conditions that have never had treatment options, like autism and brain injury.

The first cord blood stem cell transplant, an international effort between physicians in the U.S. and Europe, was performed in France in 1988. Stem cells collected from a newborns umbilical cord blood were used to save the life of her brother, a 5-year-old with Fanconi Anemia. Since then, there have been more than 40,000 cord blood transplants performed worldwide.

Now standard of care for cancers of the blood and a host of other life-threatening diseases, blood forming stem cells for transplantation can be collected from bone marrow, circulating bloodor a newborn babys umbilical cord blood. Some experts believe cord blood contains nearly 10 times the number of stem cells found in bone marrow.

Because umbilical cord stem cells are less mature than adult bone marrow stem cells, they are also less likely to be rejected and can be used when there isnt a perfect match.

Between these threeoptions, the easiest collection by far is from umbilical cord and placental tissue after a baby is born and the umbilical cord has been cut, at no risk to mother or child, in a process that typically takes 5 to 10 minutes. The cells are then frozen in liquid nitrogen and can be stored indefinitely in private or public cord blood banks.

To store your babys cord blood for use by your child and your family only, you make arrangements with a private cord blood bank ahead of delivery to collect and store the cells; the cost to you includes a collection fee of $1,500 to $2,000 and an annual storage fee of $100 to $125.

If you cant afford or dont wish to save your babys cord blood stem cells, you can donate them to a public cord blood bank at no cost to you or your family.

Its the equivalent of registering these potentially life-saving cells with the national bone marrow registry; they will be available to the families of other children who need to find a bone marrow match after a devastating diagnosis. Without information and education, however, 95% of all cord blood is discarded as medical waste.

Right now, there is no public cord banking option in Kentucky, although public cord blood banking is highly recommended by both the American Academy of Pediatrics (AAP) and the American Medical Association (AMA). There are fewer than 25 public or hybrid cord blood banks in the U.S., many limited to a specific geographic area. None of them include Kentucky.

The chances of finding a bone marrow match in your family are only about 25%, making the bone marrow and umbilical cord blood registries a lifeline in desperate situations. Odds are worse for African Americans and other ethnic minorities who are underrepresented on the registry and ethnicity matters in a bone marrow transplant.

Donating cord blood cells to a public bank adds to the library of cells that may save someones life and increases the chance of a match for all of us. Who benefits most? Children, patients with rare human leukocyte antigen (HLA) types and ethnic minorities.

We need to do two things: Make public cord blood banking an option in the commonwealth of Kentucky, and then encourage conversations between health care providers and expectant parents about preserving these life-saving cells.

There are 28 states with legislation that ask or mandates physicians to talk to expectant parents about cord blood banking. Kentucky is not one of them, but most of our surrounding states have such legislation in place.

Through a long-standing relationship between the National Stem Cell Foundationand world-renowned cord blood expert Dr. Joanne Kurtzberg, we have a path forward for training hospitals and collecting cells for storage at the Carolinas Cord Blood Bank (CCBB), one of the largest public cord blood banks in the world. Dr. Kurtzberg directs both the Pediatric Blood and Marrow Transplant (PBMT) program at Duke University and the CCBB.

She performed the worlds first unrelated cord blood transplant in 1993, paving the way for this now routine source of donor cells for children who need a bone marrow transplant and dont have a matched donor. She established the CCBB in 1998.

Paula Grisanti is CEO of the National Stem Cell Foundation.(Photo: provided)

While weve initiated discussions between Louisville hospital systems and the CCBB, we need to begin the process of education for parents, nursing and medical school students, residents, midwives, practicing OB-GYNs and the general public.

What a waste to discard these life-saving cells the future of current and developing therapies for disabling and life-threatening diseases depends on our ability to make sure that doesnt happen.

Dr. Paula Grisanti is CEO and a founding member of the National Stem Cell Foundation, headquartered in Louisville, Kentucky. She holds a D.M.D. and MBA from the University of Louisville and has been actively involved in new venture start-ups for most of her career.

Read or Share this story: https://www.courier-journal.com/story/opinion/2020/11/09/expectant-parents-need-to-know-benefits-of-cord-blood-banking/6064540002/

See more here:
It's time for Kentucky to talk to expectant parents about benefits of cord blood banking - Courier Journal

Global Stem Cell Therapy Market 2020 : Analysis of Expansion Strategy on Industry, Growth Factors and Expected CAGR Of Top Leaders, Upcoming…

By adminNovember 9, 2020Stem Cell Treatment

Global Stem Cell Therapy Market report presents a detailed analysis of the industry by size, growth rate, key players, regions, product types & applications. Stem Cell Therapy Market report evaluates key factors that affected market growth and with the help of previous figures this report elaborates current scenario and forecast of Stem Cell Therapy industry.

Stem Cell Therapy Market report focuses on the top players in market, with capacity, import/export, supply, consumption, production, price, contact information, revenue and market share for each manufacturer and gross margin by regions.

Final Report will add the analysis of the impact of COVID-19 on this Industry.

TO UNDERSTAND HOW COVID-19 IMPACT IS COVERED IN THIS REPORT REQUEST SAMPLE

Stem Cell Therapy top manufacturers with production, price, and market share for each manufacturer includes:

Get a sample copy of the report @https://www.360marketupdates.com/enquiry/request-sample/14839238

Market Segment byProductTypesconsidering Production, Revenue (Value), Price Trends:

Market Segment byApplicationsconsidering Consumption Growth Rate and Market Share:

Stem Cell Therapy: Regional analysis includes

Fill the Pre-Order Enquiry form for the report @https://www.360marketupdates.com/enquiry/pre-order-enquiry/14839238

Scope of Stem Cell Therapy:

The Global Stem Cell Therapy will reach million USD by the end of 2026, growing at a CAGR during 2020-2026. The objectives of this study are to define, segment, and project the size of the market based on company, product type, end-user, and key regions.

Key Features of Stem Cell Therapy Research Report:

Finally, this report covers the market landscape and its growth prospects over the coming years, the Report also brief deals with the product life cycle, comparing it to the relevant products from across industries that had already been commercialized details the potential for various applications, discussing about recent product innovations and gives an overview on potential regional market shares.

Purchase this report (Price 3460 USD for a single-user license) @https://www.360marketupdates.com/purchase/14839238

Name: Mr. Ajay More

Email:[emailprotected]

Organization: 360 Market Updates

Phone: +1 4242530807 /+44 203 239 8187

OUR OTHER REPORTS:

Global Lauroyl Peroxide Market Report 2020 Industry Trends, Share and Size, Expected CAGR, Top Manufacturers and Consumer Analysis across the Region and Globe, Opportunities and Growth till 2026

Global Direct Fed Microbial (DFM) Market Analysis Report 2020 : Current Industry Trends, Share and Size, Expected CAGR, Top Leading Players Data and Analysis of Future Development and Prospects till 2026

Global Crystal Jewelry Market Analysis Report 2020 : Current Industry Trends, Share and Size, Expected CAGR, Top Leading Players Data and Analysis of Future Development and Prospects till 2026

Global Surgical Cutting Devices Market Research Report 2020 Business Growth Rate Projection with CAGR of 4.57% and Current Trends with Regional Analysis and Prospects

Portable Medical and Healthcare Devices Market Report 2020 Indepth Analysis on Market Share, Size, Growth Rate and Factors, Future Developments and Prospects

The rest is here:
Global Stem Cell Therapy Market 2020 : Analysis of Expansion Strategy on Industry, Growth Factors and Expected CAGR Of Top Leaders, Upcoming...

Stem Cell Banking Market 2020 analysis with Key Players, Applications, Trends and Forecasts by 2028|Esperite, Caladrius Biosciences, Via Cord, CBR…

By adminNovember 9, 2020Stem Cell Treatment

Since the outbreak of the COVID-19 virus in December 2019, the disease has spread to almost 100 countries cross the globe, with the World Health Organization (WHO) calling it a public health emergency. The global impact of coronary virus disease 2019 (COVID-19) is already beginning to be felt and will have a major impact on the industry in 2020. COVID-19 will influence the global economy in three main ways: by directly influencing production and demand, by creating supply chains and market disruptions, and by having a financial effect on businesses and financial markets.

Whats the Effect of the Covid-19 Outbreak on Stem Cell Banking?

The global demand for Stem Cell Banking is projected to grow dramatically over the forecast period from 2020 to 2026. In 2020, the market was rising at a steady pace and, with the approach being embraced by main players, the market is predicted to increase over the estimated horizon.

The study comes out as an intelligent and comprehensive appraisal tool as well as a reliable guide that will help you maintain a solid place in the global Stem Cell Banking industry. This includes Porters Five Powers and PESTLE research to equip the company with critical knowledge and comparative statistics on the Global Stem Cell Banking Industry. We also given an in-depth review of the Vendor Environment to give you a full understanding of the present and potential business scenarios of the global Stem Cell Banking industry. Our researchers are using the new primary and secondary analysis methods and methods to produce detailed and reliable market research studies.

The Stem Cell Banking market trend study method involves a study of numerous factors impacting the sector, including regulatory regulation, competitive dynamics, historical statistics, market climate, existing market developments, new technology, technological advancement and technical progress in relevant sectors, and market threats, market obstacles, opportunities and challenges. In addition to the comprehensive research Price, Position , Size & Growth, Latest News & Trends, Expansion Plan, Current Market Strategy, Top Firms, Revenues, Revenue & Competitors Review, Production and Consumption, Demand & Supply, Industry and Sector Research, Impact of Covid 19 (Buyers & Sellers) and Forecast.

Regions served by the Stem Cell Banking Market:

Get A PDF Sample of Stem Cell Banking Report: https://www.precisionmarketreports.com/download-sample/20646

Note: In order to have more reliable demand predictions, all of our publications will be revised before delivery, taking into account the effects of COVID-19.

Segments Covered:

Each segment of the global market for Stem Cell Banking is extensively assessed in the research review. The segmental review provided in the report recognises key opportunities accessible across leading segments in the global Stem Cell Banking industry. The geographical analysis of the global market for Stem Cell Banking contained in the report allows readers to obtain a sound understanding of the growth of various geographic markets over the last few years and even to the future. We have presented a comprehensive report on the vital dynamics of the global Stem Cell Banking industry, including market effect and market impact factors, drivers, threats, limitations, developments and prospects. The research report also contains other forms of analysis, such as qualitative and quantitative ones.

The market is driven by factors such as easy method of extraction of stem cells from the samples, increasing birth rate, increased awareness of stem cell therapeutics, and increasing potentials of stem cell treatment. Alongside, the collaboration among the cord blood banks, increasing investments and fundings, and automation of procedures for the banking of stem cells are providing opportunities for the growth of the stem cell banking market. However, intense competition, high operating costs, changes in legal regulations, and high entry barriers are the major factors hampering the market growth. Market Analysis: The ?Stem Cell Banking Market? is estimated to witness a CAGR of 16.4% during the forecast period 2017?2023. The market is analyzed based on three segments, namely product types, end-users, and regions. Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (RoW). North America is set to be the leading region for the stem cell banking market growth followed by Europe. Asia Pacific and RoW are set to be the emerging regions. India, China, and Japan are set to be the most attractive destinations due to the large untapped market. Product Types Analysis: The stem cell banking market by products is segmented into umbilical cord blood & cord tissue, and adult stem cell banking. The umbilical cord blood & tissue occupies the major share in the market and is also expected to grow at a fast CAGR during the forecast period. The dental stem cell banking and menstrual blood stem cell banking are the latest diversifications in the stem cell banking market. The market is also witnessing various mergers, acquisitions, and collaborations among the top players, which is defining the future of the global stem cell banking market. Key Players: Esperite, Caladrius Biosciences, Via Cord, CBR Systems, Smart Cells, Life Cell, China Cord Blood, Cryo-Cell, StemCyte, Cordvida, ViaCord, Cryoviva, and other predominate & niche players. Competitive Analysis: These days, stem cell banks exist in most of the developed and developing nations. Around 450 companies are publicizing cord blood banking services internationally, which signifies intense competition in the market. Globally, China Cord Blood Corporation (CCBC) is expected to be the fastest growing stem cell bank worldwide and in the US, it is Amricord. In 2014, the company Amricord achieved 2,200% growth rate from 2011-2013. Future Health Biobank, American Cryostem, Adicyte, Adisave, Celltex, and Vault Stem currently hold around two-thirds of the Mesenchymal Stem Cells (MSC) storage market. However, at present, these companies are still trivial but are swiftly intensifying. Cryostem witnessed its revenue to nearly double in 2016 from $400,000 to almost $800,000. Benefits: The report provides complete details about the usage and adoption rate of stem cell banking in various regions. With that, key stakeholders can know about the major trends, drivers, investments, vertical player?s initiatives, government initiatives toward the stem cell therapy and banking adoption in the upcoming years along with the details of commercial devices available in the market. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.

specific verticals to analyze before investing or expanding the business in this market.

Stem Cell Banking Market Share analysis is given for foreign markets, including growth patterns, competitive landscape analysis and the development status of key regions. Production policies and plans are debated, and manufacturing procedures and cost systems are also analysed. This report also sets out the import / export consumption, supply and demand figures, costs, prices, revenues and gross margins. For each manufacturer concerned, this report analyses its Stem Cell Banking manufacturing sites, capability, development, ex-factory price and revenue and market share in the global market Global Stem Cell Banking Report 2020 offers unique vital statistics, results, facts, developments and competitive landscape specifics for this niche market.

Note: In order to have more reliable demand predictions, all of our publications will be revised before delivery, taking into account the effects of COVID-19.

Competitive Analysis: The Stem Cell Banking Industry study explores the business landscape by evaluating leading players on the industry. The business profile of leading industry players is included in this study by Porters Five Strength Analysis and Supply Chain Analysis. In addition, the strategies of corporations to grow their market by mergers, acquisitions and other business growth initiatives are addressed in the report. The financial metrics to be calculated include sales, profits and overall revenues generated by key market players.

Main findings of the Stem Cell Banking Market Report:

Note: In order to have more reliable demand predictions, all of our publications will be revised before delivery, taking into account the effects of COVID-19.

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, and Chart) @: https://www.precisionmarketreports.com/download-sample/20646

The Stem Cell Banking Market Outlook offers key information on the state of the industry and is a reliable source of insight and insight for businesses and individuals involved in the market.

Table of Contents:

Chapter 1:

Preface

Chapter 2:

What is the Impact of Covid-19 Outbreak on the Market?

Chapter 3:

Quarterly Competitive Assessment 2020:

Chapter 4:

Assumptions and Research Methodologies

Chapter 5:

Executive Summary: Global Stem Cell Banking

Chapter 6:

Market Variables, Trends & Scope

Chapter 7:

Market Structure Analysis

Any query? Enquire Here for Discount (COVID-19 Impact Analysis Updated Sample): https://www.precisionmarketreports.com/download-sample/20646

Note: In order to have more reliable demand predictions, all of our publications will be revised before delivery, taking into account the effects of COVID-19.

Purchase this report (Price With the downturn in world economic growth, the Stem Cell Banking industry has also had some effects, but has remained reasonably positive in the last four years. Stem Cell Banking industry size to sustain the average annual growth rate of XX from USD million in 2019 to USD million in 2020.Report analysts expect that the market size of Stem Cell Banking will be further increased in the coming years. We expect the market value of Stem Cell Banking to hit USD XX million by 2024.

About Us:

Our committed efforts are aimed at broadening the traditional market research approach to a result-driven market expansion strategy. We remain determined to keep the interests of our customers in mind so that the target market can be reached. In order to do so, we make sense of the downsides, opportunities, circumstances and valuations by leveraging our well-founded methodologies and skills to allow our clients to experience creative ideas and outcomes.

Contact Person:Mr.Brian (Business Project Head) 169, Elisenthal, North Rhine- Westphalia, Rhehin- Sieg- Kreis,Windeck, Hohnrath, Germany, DE- 51570. Phone:+1 (845) 377-0269 Website:www.precisionmarketreports.com Email:[emailprotected] /[emailprotected]

Global Stem Cell Therapy Market Growth Factor with Regional Forecast, Segmentation, Investment Opportunities, Industry Research and End User Analysis…

By adminNovember 9, 2020Stem Cell Medicine

The Stem Cell Therapy Market study describes the current market size and market forecast, market prospects, main drivers and constraints, regulatory scenario, industry trend, PESTLE analysis, PORTER analysis, new product approvals / launch, promotion and marketing campaigns, pricing analysis , competitive environment to assist companies in decision-making. The data from the study is focused on current and historical market dynamics that assist in decisions related to investment.

Stem Cell Therapy offers fundamental industry overview representing market trends, company profiles, growth drivers, market scope and Stem Cell Therapy size estimation. The valuable Stem Cell Therapy industry insights, type, application, deployment status and research regions are studied. A thorough analysis of gross margin view, trade news, industry plans and policies, constraints are explained. A complete Stem Cell Therapy industry scenario is explained from 2014 to 2019 and forecast estimates are presented from 2020-2027. The productions, industry chain analysis, gross margin structure and deployment models are stated in detail. Top regions analysed in the report include North America, South America, Europe, Asia-Pacific, Middle East & Africa and the rest of the world. The Stem Cell Therapy industry presence and maturity analysis will lead to investment feasibility and development scope.

Get A Free Sample Copy Here:

https://www.reportspedia.com/report/business-services/2015-2027-global-stem-cell-therapy-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/57925#request_sample

Stem Cell Therapy Market Leading Players (2019-2027):

Celgene Corporation Osiris Therapeutics, Inc. Pharmicell Co., Ltd MEDIPOST Co., Ltd. Promethera Biosciences Fibrocell Science, Inc. Holostem Terapie Avanzate S.r.l. Cytori Therapeutics Nuvasive, Inc. RTI Surgical, Inc. Anterogen Co., Ltd. RTI Surgical, Inc

Market Segment Analysis

By Types:

Adult Stem Cells Human Embryonic Induced Pluripotent Stem Cells Very Small Embryonic Like Stem Cells

By Applications:

Regenerative Medicine Drug Discovery and Development

By Region

North America

Europe

Asia-Pacific

LAMEA

Ask for Discount @:

https://www.reportspedia.com/discount_inquiry/discount/57925

Stem Cell Therapy Industry Report addresses different regions like North America, Europe, Asia-Pacific, Middle East & Africa and Latin America. The production value, gross margin analysis, development trend, and Stem Cell Therapy market positioning is explained. The industrial chain study, potential buyers, distributors and traders details are explained. The challenges to the growth and market restraints are explained. The market maturity study, investment scope and gross margin study are profiled. The production process structure, market share, manufacturing cost and Stem Cell Therapy saturation analysis is covered. This will helps the industry aspirants to analysis growth feasibility and development plans.

A special highlight on cost structure, import-export scenario and sales channels of Stem Cell Therapy industry is presented. The benchmarking products, dynamic market changes, upstream raw material and downstream buyers analysis are presented. The business trends, key players analysis and product segment study are explained. The regional SWOT analysis, gross margin analysis, application analysis and industry barriers are explained. The value, volume and consumption from 2019-2027 is portrayed. All the essential details like pricing structure of raw materials, labour cost, sales channels and downstream buyers are presented.

Inquire Before Buying Or Ask For Custom Requirement:

In the next segment, the forecast Stem Cell Therapy industry perspective is covered. Under forecast statistics, the market value, volume and consumption forecast from 2019-2027 is explained. Stem Cell Therapy regional analysis for major regions and countries in this region is stated. The study of new Stem Cell Therapy industry aspirants and analysts opinions for this industry is presented. The limitations to the industry growth, market risks, Stem Cell Therapy growth opportunities and market trends are viewed. The revenue, Stem Cell Therapy market status, past market performance and product details are presented.

Salient Features Of The Report:

The Stem Cell Therapy report serves as a vital guide in portraying present and forecast industry statistics and market size. The supply/ demand situation, gross margin view and competitive profile of top Stem Cell Therapy players are presented. The Stem Cell Therapy market breakdown by product, type, application and regions will provide sophisticated and precise analysis. Recent developments in Stem Cell Therapy industry, growth opportunities, constraints are studied completely. Also, new product launch events, mergers & acquisitions of Stem Cell Therapy, and industry plans and policies are covered.

The revenue estimates of Stem Cell Therapy market based on top industry players, their product type, applications and regions is studied. The cost structures, gross margin view, sales channel analysis and value chain is explained. In the next segment, the SWOT analysis of players, cost structures, traders, distributors and dealers are listed. The forecast study on Stem Cell Therapy industry will be useful for business plans and growth analysis.

To know More Details About Stem Cell Therapy Market research Report @:

Name: Alex White

Phone: US: +1(806)4400782/ UK: +44 33 3303 4979

Email: [emailprotected]

See the original post:
Global Stem Cell Therapy Market Growth Factor with Regional Forecast, Segmentation, Investment Opportunities, Industry Research and End User Analysis...

Worldwide Regenerative Medicine Industry to 2025 – Featuring Allergan, Amgen and Baxter International Among Others – PRNewswire

By adminNovember 9, 2020Stem Cell Medicine

DUBLIN, Nov. 9, 2020 /PRNewswire/ -- The "Regenerative Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.

The global regenerative medicine market grew at a CAGR of around 16% during 2014-2019. Regenerative medicine refers to a branch of biomedical sciences aimed at restoring the structure and function of damaged tissues and organs. It involves the utilization of stem cells that are developed in laboratories and further implanted safely into the body for the regeneration of damaged bones, cartilage, blood vessels and organs. Cellular and acellular regenerative medicines are commonly used in various clinical therapeutic procedures, including cell, immunomodulation and tissue engineering therapies. They hold potential for the effective treatment of various chronic diseases, such as Alzheimer's, Parkinson's and cardiovascular disorders (CVDs), osteoporosis and spinal cord injuries.

The increasing prevalence of chronic medical ailments and genetic disorders across the globe is one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is prone to various musculoskeletal, phonological, dermatological and cardiological disorders, is stimulating the market growth. In line with this, widespread adoption of organ transplantation is also contributing to the market growth. Regenerative medicine minimizes the risk of organ rejection by the body post-transplant and enhances the recovery speed of the patient.

Additionally, various technological advancements in cell-based therapies, such as the development of 3D bioprinting techniques and the adoption of artificial intelligence (AI) in the production of regenerative medicines, are acting as other growth-inducing factors. These advancements also aid in conducting efficient dermatological grafting procedures to treat chronic burns, bone defects and wounds on the skin. Other factors, including extensive research and development (R&D) activities in the field of medical sciences, along with improving healthcare infrastructure, are anticipated to drive the market further. Looking forward, the publisher expects the global regenerative medicine market to continue its strong growth during the next five years.

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Allergan PLC (AbbVie Inc.), Amgen Inc., Baxter International Inc., BD (Becton, Dickinson and Company), Integra Lifesciences Holdings Corporation, Medtronic plc, Mimedx Group Inc., Novartis AG, Osiris Therapeutics Inc. (Smith & Nephew plc) and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

Key Topics Covered:

1 Preface

2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction 4.1 Overview 4.2 Key Industry Trends

5 Global Regenerative Medicine Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast

6 Market Breakup by Type 6.1 Stem Cell Therapy 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Biomaterial 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Tissue Engineering 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Others 6.4.1 Market Trends 6.4.2 Market Forecast

7 Market Breakup by Application 7.1 Bone Graft Substitutes 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Osteoarticular Diseases 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Dermatology 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Cardiovascular 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Central Nervous System 7.5.1 Market Trends 7.5.2 Market Forecast 7.6 Others 7.6.1 Market Trends 7.6.2 Market Forecast

8 Market Breakup by End User 8.1 Hospitals 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Specialty Clinics 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Others 8.3.1 Market Trends 8.3.2 Market Forecast

9 Market Breakup by Region 9.1 North America 9.1.1 United States 9.1.1.1 Market Trends 9.1.1.2 Market Forecast 9.1.2 Canada 9.1.2.1 Market Trends 9.1.2.2 Market Forecast 9.2 Asia Pacific 9.2.1 China 9.2.1.1 Market Trends 9.2.1.2 Market Forecast 9.2.2 Japan 9.2.2.1 Market Trends 9.2.2.2 Market Forecast 9.2.3 India 9.2.3.1 Market Trends 9.2.3.2 Market Forecast 9.2.4 South Korea 9.2.4.1 Market Trends 9.2.4.2 Market Forecast 9.2.5 Australia 9.2.5.1 Market Trends 9.2.5.2 Market Forecast 9.2.6 Indonesia 9.2.6.1 Market Trends 9.2.6.2 Market Forecast 9.2.7 Others 9.2.7.1 Market Trends 9.2.7.2 Market Forecast 9.3 Europe 9.3.1 Germany 9.3.1.1 Market Trends 9.3.1.2 Market Forecast 9.3.2 France 9.3.2.1 Market Trends 9.3.2.2 Market Forecast 9.3.3 United Kingdom 9.3.3.1 Market Trends 9.3.3.2 Market Forecast 9.3.4 Italy 9.3.4.1 Market Trends 9.3.4.2 Market Forecast 9.3.5 Spain 9.3.5.1 Market Trends 9.3.5.2 Market Forecast 9.3.6 Russia 9.3.6.1 Market Trends 9.3.6.2 Market Forecast 9.3.7 Others 9.3.7.1 Market Trends 9.3.7.2 Market Forecast 9.4 Latin America 9.4.1 Brazil 9.4.1.1 Market Trends 9.4.1.2 Market Forecast 9.4.2 Mexico 9.4.2.1 Market Trends 9.4.2.2 Market Forecast 9.4.3 Others 9.4.3.1 Market Trends 9.4.3.2 Market Forecast 9.5 Middle East and Africa 9.5.1 Market Trends 9.5.2 Market Breakup by Country 9.5.3 Market Forecast

10 SWOT Analysis 10.1 Overview 10.2 Strengths 10.3 Weaknesses 10.4 Opportunities 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis 12.1 Overview 12.2 Bargaining Power of Buyers 12.3 Bargaining Power of Suppliers 12.4 Degree of Competition 12.5 Threat of New Entrants 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 Allergan PLC (AbbVie Inc.) 14.3.1.1 Company Overview 14.3.1.2 Product Portfolio 14.3.1.3 Financials 14.3.1.4 SWOT Analysis 14.3.2 Amgen Inc. 14.3.2.1 Company Overview 14.3.2.2 Product Portfolio 14.3.2.3 Financials 14.3.2.4 SWOT Analysis 14.3.3 Baxter International Inc. 14.3.3.1 Company Overview 14.3.3.2 Product Portfolio 14.3.3.3 Financials 14.3.3.4 SWOT Analysis 14.3.4 BD (Becton, Dickinson and Company) 14.3.4.1 Company Overview 14.3.4.2 Product Portfolio 14.3.4.3 Financials 14.3.4.4 SWOT Analysis 14.3.5 Integra Lifesciences Holdings Corporation 14.3.5.1 Company Overview 14.3.5.2 Product Portfolio 14.3.5.3 Financials 14.3.5.4 SWOT Analysis 14.3.6 Medtronic Plc 14.3.6.1 Company Overview 14.3.6.2 Product Portfolio 14.3.6.3 Financials 14.3.6.4 SWOT Analysis 14.3.7 Mimedx Group Inc. 14.3.7.1 Company Overview 14.3.7.2 Product Portfolio 14.3.7.3 Financials 14.3.8 Novartis AG 14.3.8.1 Company Overview 14.3.8.2 Product Portfolio 14.3.8.3 Financials 14.3.8.4 SWOT Analysis 14.3.9 Osiris Therapeutics Inc. (Smith & Nephew plc) 14.3.9.1 Company Overview 14.3.9.2 Product Portfolio 14.3.10 Thermo Fisher Scientific Inc. 14.3.10.1 Company Overview 14.3.10.2 Product Portfolio 14.3.10.3 Financials 14.3.10.4 SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/gcpeaa

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager [emailprotected]

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

Her favorite part of research was the patients, so she switched to primary… – Bothell-Kenmore Reporter

By adminNovember 9, 2020Stem Cell Medicine

Dr. Adewunmi Nugas pediatric and internal medicine practice is open to people of all ages, from newborns to geriatrics. Find her at Pacific Medical Centers (PacMed) Canyon Park, 1909 214th St. SE , in Bothell.

Making Bothell healthier by improving access, representation, and mentoring the next generation

Some people live by the adage, if it aint broke, dont fix it. When Dr. Adewunmi (Ade) Nuga looks at the world she asks a different question: could we make this even better?

Dr. Nuga is now a primary care physician at Pacific Medical Centers (PacMed) Canyon Park, but before she went to medical school she earned a PhD in Microbiology and conducted medical research.

One of my research areas was retroviruses, which is the class of virus that HIV belongs to. I wanted to understand why patients with HIV cant stop taking the medications to treat it, even when theyve taken those medications for decades. Where is the virus hiding in the body?

Advances in medications mean patients with HIV can now expect to live an average lifespan, but that wasnt good enough for Dr. Nuga. She hopes her research into bone marrow stem cells will contribute to a cure.

Only two people in the world are confirmed to have been cured of HIV, and both of them received a stem cell transplant as part of their treatment, she says.

Coordinating your care

HIV treatment is not yet part of Dr. Nugas practice, but as a primary care physician she coordinates with specialists and ensures her patients receive comprehensive care for the best possible outcomes. Since people living with HIV can expect to live an average lifespan, they need to continue caring for other aspects of their health in addition to HIV care cancer screenings, mental health, and other ongoing primary care.

Think of Dr. Nuga as your health care quarterback: calling plays and adapting strategies on the fly to develop a treatment plan that works for you. That may mean adjusting doses to your weight and age, but it could also mean adjusting referrals to accommodate your culture, social class or even access to transportation.

I want to address the barriers to care and deliver healthcare to everyone that needs it, regardless of their status. The resources at PacMed are a big help I can coordinate with care managers and community health liaisons to make sure nobody falls through the cracks, she says.

Dr. Nuga loves taking care of patients of all ages, life stages and social situations, and she has a soft spot for children.

Theres a special privilege that comes with taking care of babies from the first day of life, she says, and she hopes to have more opportunities to practice pediatrics.

Another way Dr. Nuga hopes to improve healthcare? Wit better representation throughout the system so patients see themselves in health care professionals from patient care to management.

Im hoping to get involved with the Providence mentorship program, to help inspire the next generation. The number of physicians from some minority groups hasnt changed since 1978 its kind of astounding that over 40 years we havent been able to increase representation, she says. If we improve access to care we make the environment better for everyone.

Dr. Nugas pediatric and internal medicine practice is open to people of all ages, from newborns to geriatrics. Make an appointment with Dr. Nuga for you or your child by calling 425-412-7200 or booking online. Find Dr. Nuga at Pacific Medical Centers (PacMed) Canyon Park, 1909 214th St. SE, in Bothell.

In consideration of how we voice our opinions in the modern world, weve closed comments on our websites. We value the opinions of our readers and we encourage you to keep the conversation going.

Please feel free to share your story tips by emailing editor@bothell-reporter.com.

To share your opinion for publication, submit a letter through our website https://www.bothell-reporter.com/submit-letter/. Include your name, address and daytime phone number. (Well only publish your name and hometown.) We reserve the right to edit letters, but if you keep yours to 300 words or less, we wont ask you to shorten it.

More here:
Her favorite part of research was the patients, so she switched to primary... - Bothell-Kenmore Reporter

PDS Biotech Initiates VERSATILE-002 Phase 2 Combination Trial of PDS0101-KEYTRUDA® in Recurrent/Metastatic Head and Neck Cancer in Collaboration with…

By adminNovember 9, 2020Global News Feed

VERSATILE-002 Trial for First Line Treatment of Recurrent/Metastatic Head and Neck Cancer with Combination PDS0101-KEYTRUDA® is Now Open and Recruiting Patients VERSATILE-002 Trial for First Line Treatment of Recurrent/Metastatic Head and Neck Cancer with Combination PDS0101-KEYTRUDA® is Now Open and Recruiting Patients

See the article here:
PDS Biotech Initiates VERSATILE-002 Phase 2 Combination Trial of PDS0101-KEYTRUDA® in Recurrent/Metastatic Head and Neck Cancer in Collaboration with...